Mineralys Therapeutics (MLYS) Superinvestor holders
13 of the superinvestors we track hold Mineralys Therapeutics (MLYS) in their latest 13F filings, $91M in total.
Summary
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $22M, 1.3% of the portfolio.
In their latest quarter: 7 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Wilmot Harkey Nantahala Capital Management |
Trimmed | 820,481 | $22M | 1.3% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 738,370 | $20M | 0.1% | Q2 2026 |
| Jennison Associates | Trimmed | 382,747 | $10M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 378,300 | $10M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 352,729 | $10M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 162,082 | $4M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 153,722 | $4M | 0.1% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 152,504 | $4M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 118,382 | $3M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Added | 59,640 | $2M | 0.0% | Q2 2026 |
| Alec Litowitz Magnetar Capital |
Added | 30,337 | $818,492 | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 18,000 | $485,640 | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 10,500 | $283,290 | 1.4% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 13 |
| Q1 2026 | 14 |
| Q4 2025 | 16 |
| Q3 2025 | 11 |
| Q2 2025 | 8 |
| Q1 2025 | 10 |
| Q4 2024 | 4 |
| Q3 2024 | 7 |
Questions about Mineralys Therapeutics
Which superinvestors own Mineralys Therapeutics?
13 of the superinvestors we track hold Mineralys Therapeutics (MLYS) in their latest 13F filings, $91M in total. Wilmot Harkey, Paul Tudor Jones, Jennison Associates, Jim Simons, David Shaw, Two Sigma.
Who is the largest superinvestor holder of MLYS?
The largest holder is Wilmot Harkey (Nantahala Capital Management), with $22M, 1.3% of the portfolio.
From Mineralys Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.